Newsroom

01 Jul 2019 • Morrow Sodali Pfizer Inc. (NYSE: PFE) to acquire Array BioPharma Inc. (NASDAQ: ARRY)

Pfizer Inc. (NYSE:PFE) and Array BioPharma Inc. (NASDAQ: ARRY) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array. Pfizer has agreed to acquire Array for $48 per share in cash, for a total enterprise value of approximately $11.4 billion.

Morrow Sodali is serving as the information agent for this transaction.

Download the pdf to see the Wall Street Journal ad.

01 Jul 2019 • Morrow Sodali Pfizer Inc. (NYSE: PFE) to acquire Array BioPharma Inc. (NASDAQ: ARRY)

Pfizer Inc. (NYSE:PFE) and Array BioPharma Inc. (NASDAQ: ARRY) announced that they have entered into a definitive merger agreement under which Pfizer will acquire Array. Pfizer has agreed to acquire Array for $48 per share in cash, for a total enterprise value of approximately $11.4 billion.

Morrow Sodali is serving as the information agent for this transaction.

Download the pdf to see the Wall Street Journal ad.